SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
LMAT

Lemaitre Vascular Inc (NASDAQ:LMAT)

US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
$73.61-$1.25 (-1.67%)
 
Market cap
$1.68B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 19, 2006
Market Cap$1.68B-16.3%
Revenue (ttm)$269.36M+11.8%
Net Income$63.34M+18.7%
EPS$2.75+18.5%
Shares Out22.88M
PE Ratio26.38
Forward PE23.38
Dividend$1.00(1.36%)
Ex-Dividend DateNov 19, 2026
Volume313,551
Open$75.56
Previous Close$74.86
Day's Range$73.44 - $76.01
52-Week Range$73.44 - $118.01
Beta0.49
AnalystsBuy
Price Target$97.00(+31.78%)
Earnings DateFeb 24, 2027

About LMAT

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

Address
63 Second Avenue, Burlington, MA, 01803, US
Market Cap
1.68 billion
Employees
651
Industrial Classification
Medical - Instruments & Supplies

Analyst consensus

Moderate Buy
1 Buy1 Hold0 SellAvg target $110.50 (+50.1%)

2 firms rating LMAT in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Strong
From LMAT’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-1.67%
5 Days
-6.04%
1 Month
-12.02%
6 Months
-26.03%
1 Year
-16.29%

$LMAT stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in LMAT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by LMAT's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

LMAT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

LMAT Revenue by Segment or Geography

LMAT's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New LMAT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to LMAT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in LMAT

IJRiShares Core S&P Small-Cap ETF$95.89M
SDVYFirst Trust SMID Cap Rising Dividend Achievers ETF$78.81M
VTIVanguard Morningstar Total Stock Market ETF$44.60M
IWMiShares Russell 2000 ETF$42.70M
VXFVanguard Extended Market ETF$19.69M
IWOiShares Russell 2000 Growth ETF$15.39M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from LMAT’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
62% of score
85
News & Sentiment
38% of score
58

News check: Positive earnings growth and geographic expansion offset by Q3 earnings miss and modest analyst price target reduction.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

RNSCFirst Trust Small Cap US Equity Select ETF2.93%
DVGRDAC 3D Dividend Growth ETF2.56%
MDEVFirst Trust Indxx Medical Devices ETF1.84%
XHEState Street SPDR S&P Health Care Equipment ETF1.48%
SMDVProShares S&P SmallCap 600 Dividend Aristocrats ETF1.29%
FSGSFirst Trust SMID Growth Strength ETF0.95%
PSCHInvesco S&P SmallCap Health Care ETF0.89%
AIMSAcuitas Small Cap Active ETF0.81%
SDVDFT Vest SMID Rising Dividend Achievers Target Income ETF0.74%
SDVYFirst Trust SMID Cap Rising Dividend Achievers ETF0.74%
SCOWPacer Funds Trust - Pacer S&P SmallCap 600 Quality FCF Aristocrats ETF0.38%
SLTPacer Salt High truBeta US Market ETF0.38%

Weight is the stock’s share of each fund’s holdings.